Profile picture

Doctor Ipek Aydin

Istanbul University-Cerrahpasa Institute of Cardiology, Istanbul (Turkiye)
Membership: HFA Member
Follow
Biography
Dr. İpek Aydın is a cardiology resident at Istanbul University-Cerrahpaşa, Institute of Cardiology where she started her training in June 2022. She is an early-career investigator with a strong focus on acute and chronic heart failure.Her research integrates clinical data, biomarkers and multimodality cardiovascular imaging to better understand prognosis and therapeutic response across the heart failure spectrum. She is actively involved in heart failure registries and prospective clinical research, aiming to bridge advanced imaging and precision medicine with everyday clinical practice.Dr. Aydın regularly presents her work at international scientific congresses and contributes to peer-reviewed publications. She is committed to advancing collaborative research within the heart failure community and fostering innovation in patient-centered care.She is a member of the European Society of Cardiology and the Turkish Society of Cardiology, and she speaks Turkish and English.
Logo ESC

Contributor content

Advanced pulmonary regurgitation and left ventricular non-compaction coexistence in an adult with repaired tetralogy of fallot
Presentation
Advanced pulmonary regurgitation and left ventricular non-compaction coexistence in an adult with repaired tetralogy of fallot
Galectin-3 as a biomarker to predict cardiorenal syndrome in patients with acute heart failure
Presentation
Galectin-3 as a biomarker to predict cardiorenal syndrome in patients with acute heart failure
Unmasking AL(ligth chain) amyloidosis in a patient with heart failure and syncope: a comprehensive diagnostic journey
Presentation
Unmasking AL(ligth chain) amyloidosis in a patient with heart failure and syncope: a comprehensive diagnostic journey
Unraveling the genetic tapestry of dilated cardiomyopathy: a case involving CD36 and TNXB mutations
Presentation
Unraveling the genetic tapestry of dilated cardiomyopathy: a case involving CD36 and TNXB mutations
6p.R220L is a pathogenic novel GLA gene mutation responsible for a cardiac phenotype of Fabry disease
Presentation
6p.R220L is a pathogenic novel GLA gene mutation responsible for a cardiac phenotype of Fabry disease

ESC 365 is supported by